Clinical Study

Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study

Table 1

Baseline patient characteristics divided by blood pressure group.

Group 1—target blood pressure
Group 2—elevated blood pressure
Group 3—extreme hypertension

Age64.9 (14.2)63.1 (36.6)63.4 (14.2)0.43
Weight80.5 (18.3)81.6 (17.9)80.4 (19.6)0.4
Systolic blood pressure (mmHg)120.2 (12)146.7 (16)178.5 (23.3)<0.0001
Diastolic blood pressure (mmHg)66.7 (7.6)79.3 (9.9)101 (14.4)<0.0001

Laboratory values

eGFR (mL/min/1.73 m2)33.6 (15.4)32.1 (16.1)33.9 (18.7)0.25
Urine protein creatinine ratio (mg/mmol)83.6 (146.4)116.7 (213.3)104.1 (147.7)0.005
Haemoglobin (g/dL)122.6 (16.7)125.4 (17.1)130.7 (19.2)0.003

Medications

Number of antihypertensive agents2.4 (1.4)2.4 (1.4)2.5 (1.5)0.81
Angiotensin blockade63.2%59.4%55.8%0.24
Statin60.4%57.3%49.4%0.10
Aspirin42.7%39.5%36.4%0.25
Erythropoietin stimulating agent12.8%14.5%14.3%0.62

Co-morbidities

Myocardial infarction20.4%16.8%10.4%0.045
Transient ischemic attack or stoke15%16.1%19.5%0.56
Diabetes mellitus29.8%25%26%0.097
Smoking history69.5%65.9%72.7%0.15

Primary cause of CKD

Diabetic nephropathy88 (12.2%)116 (13%)8 (10.4%)0.88
Adult polycystic kidney disease30 (4.2%)50 (5.6%)4 (5.2%)0.43
Vascular/hypertensive104 (16.4%)137 (19.0%)1 (17.5%)0.44
Glomerulonephritis/vasculitis89 (14.0%)114 (15.7%)14 (22.2%)0.19
Pyelonephritis37 (5.8%)47 (6.5%)3 (4.8%)0.78
Other/unknown298 (46.9%)286 (39.7%)23 (36.5%)0.02

Continuous variables are presented as mean (standard deviation). Categorical variables are presented as number (percentage).
eGFR: estimated glomerular filtration rate (MDRD 4-variable formula). CKD: chronic kidney disease.
Target blood pressure defined as systolic blood pressure <140 mmHg and diastolic blood pressure <80 mmHg.
Elevated blood pressure defined as systolic 140–190 mmHg or diastolic 80–100 mmHg.
Extreme blood pressure defined as systolic >190 mmHg or diastolic >100 mmHg.